NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
03/02/2026
Voltar para busca
Dado oficial do USPTO
MEDLIOR
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: VerbalEscritório: US
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
88
Atualização mais recente
04/02/2026
Classificação
Registrada
Tipo de marca
Verbal
Classes Nice
35, 42
Data de depósito
19/02/2020
Data de registro
03/02/2026
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
03/02/2026
Última transação
04/02/2026
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Fundamento do pedido
Foreign priority
Primeiro uso
2018-00-00
Primeiro uso no comércio
2018-00-00
Código do desenho
4
Tipo de titular
03
Localização do titular
Calgary, AB, CA
Examinador
SWIFT, GILBERT M
Unidade examinadora
L90
Localização atual
FILE REPOSITORY (FRANCONIA)
Titulares e representantes
Titulares
Medlior Health Outcomes Research Ltd.
Representantes
Michael J Leonard Fox Rothschild LLP
Classificação técnica
Classes Nice
Classe 35Classe 42
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 35
Business consulting servicesdeveloping research proposals and analytical plans for the healthinsurancemedical industries
Classe 42
Medical research services featuring an online listing of patient datasets for purposes of health research; medical research services featuring de-identified patient datasets to consumers for purposes of health research; providing medical and scientific research information in the field of life sciences; life sciences research; technical writing; medical research services featuring statistical analysis and reporting services for health research; medical research services featuring statistical evaluation of data from de-identified patient information; medical research consulting servicesdeveloping research proposals and analytical plans for consumers in the healthinsurance and medical industries
Publicações
Histórico de despachos e eventos da marca no USPTO.
88 publicações encontradas
R.PR
REGISTERED-PRINCIPAL REGISTER
03/02/2026
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
16/12/2025
PUBO
PUBLISHED FOR OPPOSITION
16/12/2025
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
10/12/2025
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
17/11/2025
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
22/09/2025
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
22/09/2025
ERFR
TEAS REQUEST FOR RECONSIDERATION RECEIVED
22/09/2025
GNFN
NOTIFICATION OF FINAL REFUSAL EMAILED
22/06/2025
GNFR
FINAL REFUSAL E-MAILED
22/06/2025
CNFR
FINAL REFUSAL WRITTEN
22/06/2025
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
12/06/2025
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
12/06/2025
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
08/06/2025
ERSI
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
08/06/2025
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
27/05/2025
ECDR
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
27/05/2025
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
27/05/2025
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
27/05/2025
GNS2
NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
17/03/2025
GNSI
INQUIRY TO SUSPENSION E-MAILED
17/03/2025
CNSI
SUSPENSION INQUIRY WRITTEN
17/03/2025
GNS3
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
12/09/2024
GNSL
LETTER OF SUSPENSION E-MAILED
12/09/2024
CNSL
SUSPENSION LETTER WRITTEN
12/09/2024
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
06/09/2024
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
06/09/2024
ERSI
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
05/09/2024
GNS2
NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
18/06/2024
GNSI
INQUIRY TO SUSPENSION E-MAILED
18/06/2024
CNSI
SUSPENSION INQUIRY WRITTEN
18/06/2024
GNS3
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
15/12/2023
GNSL
LETTER OF SUSPENSION E-MAILED
15/12/2023
CNSL
SUSPENSION LETTER WRITTEN
15/12/2023
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
02/12/2023
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
02/12/2023
ERSI
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
01/12/2023
GNS2
NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
17/09/2023
GNSI
INQUIRY TO SUSPENSION E-MAILED
17/09/2023
CNSI
SUSPENSION INQUIRY WRITTEN
17/09/2023
GNS3
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
13/03/2023
GNSL
LETTER OF SUSPENSION E-MAILED
13/03/2023
CNSL
SUSPENSION LETTER WRITTEN
13/03/2023
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
13/03/2023
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
13/03/2023
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
13/03/2023
ALIE
ASSIGNED TO LIE
10/03/2023
ERSI
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
03/03/2023
RCCK
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
07/09/2022
GNS2
NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
07/09/2022
GNSI
INQUIRY TO SUSPENSION E-MAILED
07/09/2022
CNSI
SUSPENSION INQUIRY WRITTEN
07/09/2022
GNS3
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
07/03/2022
GNSL
LETTER OF SUSPENSION E-MAILED
07/03/2022
CNSL
SUSPENSION LETTER WRITTEN
07/03/2022
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
16/02/2022
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
16/02/2022
ALIE
ASSIGNED TO LIE
16/02/2022
ERSI
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
11/02/2022
GNS2
NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
16/08/2021
GNSI
INQUIRY TO SUSPENSION E-MAILED
16/08/2021
CNSI
SUSPENSION INQUIRY WRITTEN
16/08/2021
GNS3
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
11/02/2021
GNSL
LETTER OF SUSPENSION E-MAILED
11/02/2021
CNSL
SUSPENSION LETTER WRITTEN
11/02/2021
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
14/01/2021
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
13/01/2021
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
13/01/2021
GAUN
NOTIFICATION OF NOTICE OF UNRESPONSIVE AMENDMENT - E-MAILED
13/01/2021
GAUD
NOTICE OF UNRESPONSIVE AMENDMENT - E-MAILED
13/01/2021
NAUD
REPORT UNRESPONSIVE AMENDMENT - COMPLETED
13/01/2021
DPCC
DIVISIONAL PROCESSING COMPLETE
23/11/2020
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
23/11/2020
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
12/11/2020
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
12/11/2020
IROA
RESPONSE TO ITU OFFICE ACTION ENTERED
12/11/2020
PARI
TEAS VOLUNTARY AMENDMENT RECEIVED
12/11/2020
INCD
ITU OFFICE ACTION ISSUED FOR DIVISIONAL REQUEST
04/11/2020
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
04/11/2020
DRRR
DIVISIONAL REQUEST RECEIVED
23/09/2020
ERTD
TEAS REQUEST TO DIVIDE RECEIVED
23/09/2020
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
13/05/2020
GNRT
NON-FINAL ACTION E-MAILED
13/05/2020
CNRT
NON-FINAL ACTION WRITTEN
13/05/2020
DOCK
ASSIGNED TO EXAMINER
07/05/2020
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
24/02/2020
NWAP
NEW APPLICATION ENTERED
22/02/2020
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace MEDLIOR ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.